Home/Filings/4/0001209191-23-048238
4//SEC Filing

Glezer Stanislav 4

Accession 0001209191-23-048238

CIK 0001294133other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 6:22 PM ET

Size

8.9 KB

Accession

0001209191-23-048238

Insider Transaction Report

Form 4
Period: 2023-09-01
Glezer Stanislav
EVP, Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-09-01$6.18/sh394$2,4357,591 total
  • Exercise/Conversion

    Common Stock

    2023-09-01+7697,985 total
  • Exercise/Conversion

    Restricted Stock Unit

    2023-09-017696,149 total
    Common Stock (769 underlying)
Footnotes (3)
  • [F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
  • [F3]Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Issuer

Inogen Inc

CIK 0001294133

Entity typeother

Related Parties

1
  • filerCIK 0001866861

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 6:22 PM ET
Size
8.9 KB